International edition Finance & trade

Monday, 12 October 2026

National Trade News

Independent coverage of global markets, trade and finance

Trading

Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test

National Trade News capital-markets note (2026-10-12): Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test (RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new… Primary source: original at Nasdaq Market Structure (nasdaq.com).

· Nasdaq Market Structure

Freenome To Present Improved Precancerous Lesion Detection Data For CRC Blood Test

(RTTNews) - On Sunday, Freenome, Inc. (FRNM) said it will present new clinical validation data for an updated version of its SimpleScreen colorectal cancer (CRC) blood-based screening test at the American College of Gastroenterology (ACG) 2026 Annual Meeting in Nashville.

Read at source

Read also